ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Erectile Dysfunction Market Research Report 2026
Published Date: 2026-03-31
|
Report Code: QYRE-Auto-11Z3168
Home | Market Reports
Global Erectile Dysfunction Market Insights and Forecast to 2028
BUY CHAPTERS

Global Erectile Dysfunction Market Research Report 2026

Code: QYRE-Auto-11Z3168
Report
2026-03-31
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eli Lilly
Pfizer Inc
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Seoul Pharma
Yabang Pharmacy
Petros Pharmaceuticals

Erectile Dysfunction Market Size

The global Erectile Dysfunction market was valued at US$ 6741 million in 2025 and is anticipated to reach US$ 10780 million by 2032, at a CAGR of 7.0% from 2026 to 2032.

Erectile Dysfunction Market

Erectile Dysfunction Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Erectile Dysfunction competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The erectile dysfunction (ED) drug market is experiencing significant growth. The main drivers of market growth include the increase in the elderly population, increased awareness of ED, innovation in treatment methods, and favorable reimbursement policies.
The prevalence of ED is rising globally, with an estimated 15% of men affected by ED each year and expected to affect 320 million people by 2025. The incidence of ED increases with age, and the growth of the elderly population is one of the key factors driving the growth of the ED drugs market.
Technological advancements such as new drug development, innovations in drug delivery systems such as sublingual tablets, topical creams, and nasal sprays are also driving market growth. Additionally, the rise of telemedicine services is changing how ED treatment is obtained.
The market is highly concentrated, with major players including Bayer, Eli Lilly, Pfizer, Teva and other companies. These companies strengthen their market positions by launching new drugs, expanding product portfolios and market coverage.
In terms of products, sildenafil (Viagra) held the largest market share in 2023, followed by tadalafil (Cialis), vardenafil (Levitra), and avanafil (Stendra).
In terms of route of administration, oral drugs accounted for the largest market share in 2023, and other routes, including topical and intraurethral delivery, are expected to grow at the fastest rate.
From a regional perspective, North America is the largest market, accounting for more than 40% of the market share, followed by Asia Pacific and Europe.
Overall, the ED drugs market is driven by several factors, including increasing geriatric population, changing lifestyles, technological advancements, and rising awareness about ED treatments. The market is expected to continue to expand as new drugs and new treatment modalities are developed.
This report delivers a comprehensive overview of the global Erectile Dysfunction market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Erectile Dysfunction. The Erectile Dysfunction market size, estimates, and forecasts are provided in terms of sales volume (Million Pill) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Erectile Dysfunction market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Erectile Dysfunction manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Erectile Dysfunction Market Report

Report Metric Details
Report Name Erectile Dysfunction Market
Accounted market size in 2025 US$ 6741 million
Forecasted market size in 2032 US$ 10780 million
CAGR 7.0%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Sildenafil
  • Tadalafil
  • Others
by Application
  • Hospital Pharmacies
  • Private Clinics
  • Retail Pharmacies
  • E-Commerce (B2B)
  • E-Commerce (B2C)
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Petros Pharmaceuticals, Seoul Pharma, Yabang Pharmacy
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Erectile Dysfunction manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Erectile Dysfunction sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Erectile Dysfunction Market growing?

Ans: The Erectile Dysfunction Market witnessing a CAGR of 7.0% during the forecast period 2026-2032.

What is the Erectile Dysfunction Market size in 2032?

Ans: The Erectile Dysfunction Market size in 2032 will be US$ 10780 million.

What is the Erectile Dysfunction Market share by region?

Ans: From a regional perspective, North America is the largest market, accounting for more than 40% of the market share, followed by Asia Pacific and Europe.

Who are the main players in the Erectile Dysfunction Market report?

Ans: The main players in the Erectile Dysfunction Market are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Petros Pharmaceuticals, Seoul Pharma, Yabang Pharmacy

What are the Application segmentation covered in the Erectile Dysfunction Market report?

Ans: The Applications covered in the Erectile Dysfunction Market report are Hospital Pharmacies, Private Clinics, Retail Pharmacies, E-Commerce (B2B), E-Commerce (B2C)

What are the Type segmentation covered in the Erectile Dysfunction Market report?

Ans: The Types covered in the Erectile Dysfunction Market report are Sildenafil, Tadalafil, Others

1 Erectile Dysfunction Market Overview
1.1 Product Definition
1.2 Erectile Dysfunction by Type
1.2.1 Global Erectile Dysfunction Market Value by Type: 2025 vs 2032
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Erectile Dysfunction by Application
1.3.1 Global Erectile Dysfunction Market Value by Application: 2025 vs 2032
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce (B2B)
1.3.6 E-Commerce (B2C)
1.4 Global Erectile Dysfunction Market Size Estimates and Forecasts
1.4.1 Global Erectile Dysfunction Revenue 2021–2032
1.4.2 Global Erectile Dysfunction Sales 2021–2032
1.4.3 Global Erectile Dysfunction Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Erectile Dysfunction Market Competition by Manufacturers
2.1 Global Erectile Dysfunction Sales Market Share by Manufacturers (2021–2026)
2.2 Global Erectile Dysfunction Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Erectile Dysfunction Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Erectile Dysfunction, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Erectile Dysfunction, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Erectile Dysfunction, Product Types and Applications
2.7 Global Key Manufacturers of Erectile Dysfunction, Date of Entry into the Industry
2.8 Global Erectile Dysfunction Market Competitive Situation and Trends
2.8.1 Global Erectile Dysfunction Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Erectile Dysfunction Players Market Share by Revenue
2.8.3 Global Erectile Dysfunction Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Erectile Dysfunction Market Scenario by Region
3.1 Global Erectile Dysfunction Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Erectile Dysfunction Sales by Region: 2021–2032
3.2.1 Global Erectile Dysfunction Sales by Region: 2021–2026
3.2.2 Global Erectile Dysfunction Sales by Region: 2027–2032
3.3 Global Erectile Dysfunction Revenue by Region: 2021–2032
3.3.1 Global Erectile Dysfunction Revenue by Region: 2021–2026
3.3.2 Global Erectile Dysfunction Revenue by Region: 2027–2032
3.4 North America Erectile Dysfunction Market Facts & Figures by Country
3.4.1 North America Erectile Dysfunction Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Erectile Dysfunction Sales by Country (2021–2032)
3.4.3 North America Erectile Dysfunction Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Erectile Dysfunction Market Facts & Figures by Country
3.5.1 Europe Erectile Dysfunction Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Erectile Dysfunction Sales by Country (2021–2032)
3.5.3 Europe Erectile Dysfunction Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Erectile Dysfunction Market Facts & Figures by Region
3.6.1 Asia Pacific Erectile Dysfunction Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Erectile Dysfunction Sales by Region (2021–2032)
3.6.3 Asia Pacific Erectile Dysfunction Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Erectile Dysfunction Market Facts & Figures by Country
3.7.1 Latin America Erectile Dysfunction Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Erectile Dysfunction Sales by Country (2021–2032)
3.7.3 Latin America Erectile Dysfunction Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Erectile Dysfunction Market Facts & Figures by Country
3.8.1 Middle East and Africa Erectile Dysfunction Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Erectile Dysfunction Sales by Country (2021–2032)
3.8.3 Middle East and Africa Erectile Dysfunction Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Erectile Dysfunction Sales by Type (2021–2032)
4.1.1 Global Erectile Dysfunction Sales by Type (2021–2026)
4.1.2 Global Erectile Dysfunction Sales by Type (2027–2032)
4.1.3 Global Erectile Dysfunction Sales Market Share by Type (2021–2032)
4.2 Global Erectile Dysfunction Revenue by Type (2021–2032)
4.2.1 Global Erectile Dysfunction Revenue by Type (2021–2026)
4.2.2 Global Erectile Dysfunction Revenue by Type (2027–2032)
4.2.3 Global Erectile Dysfunction Revenue Market Share by Type (2021–2032)
4.3 Global Erectile Dysfunction Price by Type (2021–2032)
5 Segment by Application
5.1 Global Erectile Dysfunction Sales by Application (2021–2032)
5.1.1 Global Erectile Dysfunction Sales by Application (2021–2026)
5.1.2 Global Erectile Dysfunction Sales by Application (2027–2032)
5.1.3 Global Erectile Dysfunction Sales Market Share by Application (2021–2032)
5.2 Global Erectile Dysfunction Revenue by Application (2021–2032)
5.2.1 Global Erectile Dysfunction Revenue by Application (2021–2026)
5.2.2 Global Erectile Dysfunction Revenue by Application (2027–2032)
5.2.3 Global Erectile Dysfunction Revenue Market Share by Application (2021–2032)
5.3 Global Erectile Dysfunction Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Company Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Erectile Dysfunction Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Eli Lilly Erectile Dysfunction Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Erectile Dysfunction Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pfizer Erectile Dysfunction Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Company Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Erectile Dysfunction Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Bayer Erectile Dysfunction Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 BaiYunShan General Factory
6.4.1 BaiYunShan General Factory Company Information
6.4.2 BaiYunShan General Factory Description and Business Overview
6.4.3 BaiYunShan General Factory Erectile Dysfunction Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 BaiYunShan General Factory Erectile Dysfunction Product Portfolio
6.4.5 BaiYunShan General Factory Recent Developments/Updates
6.5 S.K. Chemicals
6.5.1 S.K. Chemicals Company Information
6.5.2 S.K. Chemicals Description and Business Overview
6.5.3 S.K. Chemicals Erectile Dysfunction Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 S.K. Chemicals Erectile Dysfunction Product Portfolio
6.5.5 S.K. Chemicals Recent Developments/Updates
6.6 Teva Pharma
6.6.1 Teva Pharma Company Information
6.6.2 Teva Pharma Description and Business Overview
6.6.3 Teva Pharma Erectile Dysfunction Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Teva Pharma Erectile Dysfunction Product Portfolio
6.6.5 Teva Pharma Recent Developments/Updates
6.7 Dong-A ST
6.7.1 Dong-A ST Company Information
6.7.2 Dong-A ST Description and Business Overview
6.7.3 Dong-A ST Erectile Dysfunction Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Dong-A ST Erectile Dysfunction Product Portfolio
6.7.5 Dong-A ST Recent Developments/Updates
6.8 Petros Pharmaceuticals
6.8.1 Petros Pharmaceuticals Company Information
6.8.2 Petros Pharmaceuticals Description and Business Overview
6.8.3 Petros Pharmaceuticals Erectile Dysfunction Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Petros Pharmaceuticals Erectile Dysfunction Product Portfolio
6.8.5 Petros Pharmaceuticals Recent Developments/Updates
6.9 Seoul Pharma
6.9.1 Seoul Pharma Company Information
6.9.2 Seoul Pharma Description and Business Overview
6.9.3 Seoul Pharma Erectile Dysfunction Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Seoul Pharma Erectile Dysfunction Product Portfolio
6.9.5 Seoul Pharma Recent Developments/Updates
6.10 Yabang Pharmacy
6.10.1 Yabang Pharmacy Company Information
6.10.2 Yabang Pharmacy Description and Business Overview
6.10.3 Yabang Pharmacy Erectile Dysfunction Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Yabang Pharmacy Erectile Dysfunction Product Portfolio
6.10.5 Yabang Pharmacy Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Erectile Dysfunction Industry Chain Analysis
7.2 Erectile Dysfunction Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Erectile Dysfunction Production Mode & Process Analysis
7.4 Erectile Dysfunction Sales and Marketing
7.4.1 Erectile Dysfunction Sales Channels
7.4.2 Erectile Dysfunction Distributors
7.5 Erectile Dysfunction Customer Analysis
8 Erectile Dysfunction Market Dynamics
8.1 Erectile Dysfunction Industry Trends
8.2 Erectile Dysfunction Market Drivers
8.3 Erectile Dysfunction Market Challenges
8.4 Erectile Dysfunction Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Eli Lilly
Pfizer Inc
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Seoul Pharma
Yabang Pharmacy
Petros Pharmaceuticals
List of Tables
 Table 1. Global Erectile Dysfunction Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Erectile Dysfunction Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Erectile Dysfunction Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Erectile Dysfunction Sales (Million Pill) of Key Manufacturers (2021–2026)
 Table 5. Global Erectile Dysfunction Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Erectile Dysfunction Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Erectile Dysfunction Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Erectile Dysfunction Average Price (USD/Pill) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Erectile Dysfunction, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Erectile Dysfunction, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Erectile Dysfunction, Product Types and Applications
 Table 12. Global Key Manufacturers of Erectile Dysfunction, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Erectile Dysfunction Companies by Tier (Tier 1, Tier 2, Tier 3), based on Erectile Dysfunction Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Erectile Dysfunction Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Erectile Dysfunction Sales by Region (Million Pill), 2021–2026
 Table 18. Global Erectile Dysfunction Sales Market Share by Region (2021–2026)
 Table 19. Global Erectile Dysfunction Sales by Region (Million Pill), 2027–2032
 Table 20. Global Erectile Dysfunction Sales Market Share by Region (2027–2032)
 Table 21. Global Erectile Dysfunction Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Erectile Dysfunction Revenue Market Share by Region (2021–2026)
 Table 23. Global Erectile Dysfunction Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Erectile Dysfunction Revenue Market Share by Region (2027–2032)
 Table 25. North America Erectile Dysfunction Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Erectile Dysfunction Sales by Country (Million Pill), 2021–2026
 Table 27. North America Erectile Dysfunction Sales by Country (Million Pill), 2027–2032
 Table 28. North America Erectile Dysfunction Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Erectile Dysfunction Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Erectile Dysfunction Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Erectile Dysfunction Sales by Country (Million Pill), 2021–2026
 Table 32. Europe Erectile Dysfunction Sales by Country (Million Pill), 2027–2032
 Table 33. Europe Erectile Dysfunction Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Erectile Dysfunction Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Erectile Dysfunction Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Erectile Dysfunction Sales by Region (Million Pill), 2021–2026
 Table 37. Asia Pacific Erectile Dysfunction Sales by Region (Million Pill), 2027–2032
 Table 38. Asia Pacific Erectile Dysfunction Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Erectile Dysfunction Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Erectile Dysfunction Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Erectile Dysfunction Sales by Country (Million Pill), 2021–2026
 Table 42. Latin America Erectile Dysfunction Sales by Country (Million Pill), 2027–2032
 Table 43. Latin America Erectile Dysfunction Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Erectile Dysfunction Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Erectile Dysfunction Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Erectile Dysfunction Sales by Country (Million Pill), 2021–2026
 Table 47. Middle East and Africa Erectile Dysfunction Sales by Country (Million Pill), 2027–2032
 Table 48. Middle East and Africa Erectile Dysfunction Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Erectile Dysfunction Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Erectile Dysfunction Sales (Million Pill) by Type (2021–2026)
 Table 51. Global Erectile Dysfunction Sales (Million Pill) by Type (2027–2032)
 Table 52. Global Erectile Dysfunction Sales Market Share by Type (2021–2026)
 Table 53. Global Erectile Dysfunction Sales Market Share by Type (2027–2032)
 Table 54. Global Erectile Dysfunction Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Erectile Dysfunction Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Erectile Dysfunction Revenue Market Share by Type (2021–2026)
 Table 57. Global Erectile Dysfunction Revenue Market Share by Type (2027–2032)
 Table 58. Global Erectile Dysfunction Price (USD/Pill) by Type (2021–2026)
 Table 59. Global Erectile Dysfunction Price (USD/Pill) by Type (2027–2032)
 Table 60. Global Erectile Dysfunction Sales (Million Pill) by Application (2021–2026)
 Table 61. Global Erectile Dysfunction Sales (Million Pill) by Application (2027–2032)
 Table 62. Global Erectile Dysfunction Sales Market Share by Application (2021–2026)
 Table 63. Global Erectile Dysfunction Sales Market Share by Application (2027–2032)
 Table 64. Global Erectile Dysfunction Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Erectile Dysfunction Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Erectile Dysfunction Revenue Market Share by Application (2021–2026)
 Table 67. Global Erectile Dysfunction Revenue Market Share by Application (2027–2032)
 Table 68. Global Erectile Dysfunction Price (USD/Pill) by Application (2021–2026)
 Table 69. Global Erectile Dysfunction Price (USD/Pill) by Application (2027–2032)
 Table 70. Eli Lilly Company Information
 Table 71. Eli Lilly Description and Business Overview
 Table 72. Eli Lilly Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill), and Gross Margin (2021–2026)
 Table 73. Eli Lilly Erectile Dysfunction Product
 Table 74. Eli Lilly Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill), and Gross Margin (2021–2026)
 Table 78. Pfizer Erectile Dysfunction Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Bayer Company Information
 Table 81. Bayer Description and Business Overview
 Table 82. Bayer Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill), and Gross Margin (2021–2026)
 Table 83. Bayer Erectile Dysfunction Product
 Table 84. Bayer Recent Developments/Updates
 Table 85. BaiYunShan General Factory Company Information
 Table 86. BaiYunShan General Factory Description and Business Overview
 Table 87. BaiYunShan General Factory Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill), and Gross Margin (2021–2026)
 Table 88. BaiYunShan General Factory Erectile Dysfunction Product
 Table 89. BaiYunShan General Factory Recent Developments/Updates
 Table 90. S.K. Chemicals Company Information
 Table 91. S.K. Chemicals Description and Business Overview
 Table 92. S.K. Chemicals Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill), and Gross Margin (2021–2026)
 Table 93. S.K. Chemicals Erectile Dysfunction Product
 Table 94. S.K. Chemicals Recent Developments/Updates
 Table 95. Teva Pharma Company Information
 Table 96. Teva Pharma Description and Business Overview
 Table 97. Teva Pharma Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill), and Gross Margin (2021–2026)
 Table 98. Teva Pharma Erectile Dysfunction Product
 Table 99. Teva Pharma Recent Developments/Updates
 Table 100. Dong-A ST Company Information
 Table 101. Dong-A ST Description and Business Overview
 Table 102. Dong-A ST Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill), and Gross Margin (2021–2026)
 Table 103. Dong-A ST Erectile Dysfunction Product
 Table 104. Dong-A ST Recent Developments/Updates
 Table 105. Petros Pharmaceuticals Company Information
 Table 106. Petros Pharmaceuticals Description and Business Overview
 Table 107. Petros Pharmaceuticals Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill), and Gross Margin (2021–2026)
 Table 108. Petros Pharmaceuticals Erectile Dysfunction Product
 Table 109. Petros Pharmaceuticals Recent Developments/Updates
 Table 110. Seoul Pharma Company Information
 Table 111. Seoul Pharma Description and Business Overview
 Table 112. Seoul Pharma Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill), and Gross Margin (2021–2026)
 Table 113. Seoul Pharma Erectile Dysfunction Product
 Table 114. Seoul Pharma Recent Developments/Updates
 Table 115. Yabang Pharmacy Company Information
 Table 116. Yabang Pharmacy Description and Business Overview
 Table 117. Yabang Pharmacy Erectile Dysfunction Sales (Million Pill), Revenue (US$ Million), Price (USD/Pill), and Gross Margin (2021–2026)
 Table 118. Yabang Pharmacy Erectile Dysfunction Product
 Table 119. Yabang Pharmacy Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Erectile Dysfunction Distributors List
 Table 123. Erectile Dysfunction Customers List
 Table 124. Erectile Dysfunction Market Trends
 Table 125. Erectile Dysfunction Market Drivers
 Table 126. Erectile Dysfunction Market Challenges
 Table 127. Erectile Dysfunction Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Erectile Dysfunction
 Figure 2. Global Erectile Dysfunction Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Erectile Dysfunction Market Share by Type: 2025 & 2032
 Figure 4. Sildenafil Product Picture
 Figure 5. Tadalafil Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Erectile Dysfunction Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Erectile Dysfunction Market Share by Application: 2025 & 2032
 Figure 9. Hospital Pharmacies
 Figure 10. Private Clinics
 Figure 11. Retail Pharmacies
 Figure 12. E-Commerce (B2B)
 Figure 13. E-Commerce (B2C)
 Figure 14. Global Erectile Dysfunction Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Erectile Dysfunction Market Size (US$ Million), 2021–2032
 Figure 16. Global Erectile Dysfunction Sales (Million Pill), 2021–2032
 Figure 17. Global Erectile Dysfunction Average Price (USD/Pill), 2021–2032
 Figure 18. Erectile Dysfunction Report Years Considered
 Figure 19. Erectile Dysfunction Sales Share by Manufacturers in 2025
 Figure 20. Global Erectile Dysfunction Revenue Share by Manufacturers in 2025
 Figure 21. Top 5 and Top 10 Global Erectile Dysfunction Players: Market Share by Revenue in Erectile Dysfunction in 2025
 Figure 22. Erectile Dysfunction Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 23. Global Erectile Dysfunction Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 24. North America Erectile Dysfunction Sales Market Share by Country (2021–2032)
 Figure 25. North America Erectile Dysfunction Revenue Market Share by Country (2021–2032)
 Figure 26. United States Erectile Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Canada Erectile Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Europe Erectile Dysfunction Sales Market Share by Country (2021–2032)
 Figure 29. Europe Erectile Dysfunction Revenue Market Share by Country (2021–2032)
 Figure 30. Germany Erectile Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. France Erectile Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. U.K. Erectile Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Italy Erectile Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Russia Erectile Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Asia Pacific Erectile Dysfunction Sales Market Share by Region (2021–2032)
 Figure 36. Asia Pacific Erectile Dysfunction Revenue Market Share by Region (2021–2032)
 Figure 37. China Erectile Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Japan Erectile Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. South Korea Erectile Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. India Erectile Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Australia Erectile Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. China Taiwan Erectile Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Indonesia Erectile Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Thailand Erectile Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Malaysia Erectile Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Latin America Erectile Dysfunction Sales Market Share by Country (2021–2032)
 Figure 47. Latin America Erectile Dysfunction Revenue Market Share by Country (2021–2032)
 Figure 48. Mexico Erectile Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Brazil Erectile Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Argentina Erectile Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Middle East and Africa Erectile Dysfunction Sales Market Share by Country (2021–2032)
 Figure 52. Middle East and Africa Erectile Dysfunction Revenue Market Share by Country (2021–2032)
 Figure 53. Turkey Erectile Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Saudi Arabia Erectile Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. UAE Erectile Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Global Sales Market Share of Erectile Dysfunction by Type (2021–2032)
 Figure 57. Global Revenue Market Share of Erectile Dysfunction by Type (2021–2032)
 Figure 58. Global Erectile Dysfunction Price (USD/Pill) by Type (2021–2032)
 Figure 59. Global Sales Market Share of Erectile Dysfunction by Application (2021–2032)
 Figure 60. Global Revenue Market Share of Erectile Dysfunction by Application (2021–2032)
 Figure 61. Global Erectile Dysfunction Price (USD/Pill) by Application (2021–2032)
 Figure 62. Erectile Dysfunction Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Erectile Dysfunction Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Erectile Dysfunction Treatment Drugs Market Insights Forecast to 2030
Oral Erectile Dysfunction Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Erectile Dysfunction Treatment Market Insights Forecast to 2030
Erectile Dysfunction ED Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Penile Implants or Penile Prosthesis Market Research Report 2024
Sexual Dysfunction Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vardenafil Market Insights Forecast to 2030
Global Oral Medications for Erectile Dysfunction Market Research Report 2024
Erectile Dysfunction Shockwave Therapy Apparatus Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Erectile Dysfunction ESWT Units Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global ED Treatment Market Insights Forecast to 2030
Global Erectile Dysfunction Devices Market Research Report 2024
Global Female Sexual Dysfunction Treatment Drug Market Research Report 2024
Global Female Sexual Dysfunction Treatment Market Insights Forecast to 2030
Global Peyronie s Disease Treatment Market Insights Forecast to 2030
Global Drugs for Sexual Dysfunction Market Research Report 2024
Global Erectile Dysfunction Medicine Market Research Report 2024
Global Anti erectile Dysfunction ED Drugs Market Insights Forecast to 2030
Global Tadalafil Oral Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions